Innova Captab IPO Details
IPO Date	December 21, 2023 to December 26, 2023
Listing Date	December 29, 2023
Face Value	₹10 per share
Issue Price Band	₹426 to ₹448 per share
Issue Price Final	₹448 per share
Lot Size	33 Shares
Sale Type	Fresh Capital-cum-Offer for Sale
Total Issue Size	1,27,23,214 shares
(aggregating up to ₹570.00 Cr)
Fresh Issue	71,42,857 shares
(aggregating up to ₹320.00 Cr)
Offer for Sale	55,80,357 shares of ₹10
(aggregating up to ₹250.00 Cr)
Issue Type	Bookbuilding IPO
Listing At	BSE, NSE
Share Holding Post Issue	5,72,24,929 shares
Innova Captab IPO Reservation
Innova Captab IPO offers total 1,27,23,214 shares. Out of which 63,61,606 (50.00%) allocated to QIB, 25,44,643 (20.00%) allocated to QIB, 19,08,483 (15.00%) allocated to NII, 44,53,125 (35.00%) allocated to RII and 38,16,963 (30.00%) allocated to Anchor investors.

Investor Category	Shares Offered	Maximum Allottees
QIB Shares Offered	63,61,606 (50.00%)	NA
NII (HNI) Shares Offered	19,08,483 (15.00%)	NA
Retail Shares Offered	44,53,125 (35.00%)	1,34,943
Total Shares Offered	1,27,23,214 (100.00%)	
Innova Captab IPO Anchor Investors Details
Innova Captab IPO raises ₹171.00 crore from anchor investors. Innova Captab IPO Anchor bid date is December 20, 2023. Innova Captab IPO Anchor Investors list

Bid Date	December 20, 2023
Shares Offered	38,16,963
Anchor Portion Size (In Cr.)	171.00
Anchor lock-in period end date for 50% shares (30 Days)	January 26, 2024
Anchor lock-in period end date for remaining shares (90 Days)	March 26, 2024
Innova Captab IPO Timeline (Tentative Schedule)
Innova Captab IPO opens on December 21, 2023, and closes on December 26, 2023.

IPO Open Date	Thu, Dec 21, 2023
IPO Close Date	Tue, Dec 26, 2023
Tentative Allotment	Wed, Dec 27, 2023
Initiation of Refunds	Thu, Dec 28, 2023
Credit of Shares to Demat	Thu, Dec 28, 2023
Tentative Listing Date	Fri, Dec 29, 2023
Cut-off time for UPI mandate confirmation	5 PM on Tue, Dec 26, 2023
Innova Captab IPO Lot Size
Investors can bid for a minimum of 33 shares and in multiples thereof.  The following table depicts the minimum and maximum investment by Individual Investors (Retail) and HNI in terms of shares and amount.

Application	Lots	Shares	Amount
Retail (Min)	1	33	₹14,784
Retail (Max)	13	429	₹1,92,192
S-HNI (Min)	14	462	₹2,06,976
S-HNI (Max)	67	2,211	₹9,90,528
B-HNI (Min)	68	2,244	₹10,05,312
Innova Captab IPO Promoter Holding
The Promoters of the company, namely Manoj Kumar Lohariwala and Vinay Kumar Lohariwala
Promoter Holding Pre Issue	66.85%
Promoter Holding Post Issue	
Note : The value will be calculated using Equity Dilution = Share Holding Pre Issue - Share Holding Post Issue

About Innova Captab Ltd.
Incorporated in January 2005, Innova Captab Limited is a pharmaceutical company operating in three business segments. Firstly, it provides contract development and manufacturing services to Indian pharmaceutical companies. Secondly, the company has a domestic business dealing in branded generics. And thirdly, the company has an international business that deals in branded generics.

The company's product portfolio includes tablets, capsules, dry syrups, dry powder injections, ointments and liquid medicines.

In the financial year 2023 and the three months ended June 30, 2023, the company produced and sold more than 600 different types of generics. These products were distributed under the company's own brands in the Indian market through a network of approximately 5,000 distributors and stockists and over 150,000 retail pharmacies. In addition, Innova Capitab exported its branded generic products to 20 and 16 countries in FY2023 and the three months ended June 30, 2023, respectively.

As of October 31, 2023, the company employed a team of 29 scientists and engineers in its research and development laboratory. The company's manufacturing facility is located in Buddi, Haryana

The company's customer base includes Cipla, Glenmark Pharmaceuticals, Wockhardt, Corona Remedies, Emcure Pharmaceuticals, Lupin, Medley Pharmaceuticals, Eris Healthcare, Zuventus Healthcare, Ajanta Pharma, Mankind Pharma, and others.

As of October 31, 2023, the company has 200 active product registrations and 20 registrations pending renewal with international authorities. In addition, 218 new registration applications are being processed with international authorities.

Company Financials
Innova Captab Limited Financial Information (Restated Consolidated)
Innova Captab Limited's revenue increased by 16.45% and profit after tax (PAT) rose by 6.26% between the financial year ending with March 31, 2023 and March 31, 2022.

Period Ended	30 Jun 2023	31 Mar 2023	31 Mar 2022	31 Mar 2021
Assets	1,086.16	704.41	575.48	369.62
Total Income	234.37	935.58	803.41	412.03
Profit After Tax	17.59	67.95	63.95	34.50
Net Worth	294.27	276.46	208.56	144.78
Reserves and Surplus	317.51	228.51	196.61	132.82
Total Borrowing	441.90	235.19	198.18	45.03
Amount in ₹ Crore
Key Performance Indicator (KPI)
The market capitalization of Innova Captab IPO is ₹2563.70 Cr.

KPI	Values
ROE	24.58%
ROCE	22.61%
Debt/Equity	0.85
RoNW	24.58%
Check Innova Captab IPO Peer Comparison here.
Pre IPO	Post IPO
EPS Rs	14.16	
P/E (x)	31.64	36.42
Objects of the Issue (Innova Captab IPO Objectives)
The Company proposes to utilise the Net Proceeds from the Fresh Issue towards funding the following objects:

Repayment and / or prepayment in part or in full, of certain outstanding loans of the Company;
Investment in the Subsidiary, UML, for repayment and / or prepayment in part or full of outstanding loans availed by UML;
Funding the working capital requirements; and
General corporate purposes
Innova Captab IPO Review
[Dilip Davda]  The company is a branded generic pharmaceutical products manufacturer for the domestic and international markets. It has posted growth in its top and bottom lines. Recent acquisition of Sharon Bio by the company augurs well for its synergistic growth plans. It is also gearing for new product portfolio with its upcoming new plant at Jammu. Based on FY24 annualized earnings, the issue appears fully priced, but it is poised for bright prospects post expansion. Investors may park funds for the medium to long term rewards. Read detail review...

Innova Captab IPO Subscription Status (Bidding Detail)
The Innova Captab IPO is subscribed 55.26 times on December 26, 2023 6:07:00 PM (Day 3). The public issue subscribed 17.15 times in the retail category, 116.73 times in the QIB category, and 64.95 times in the NII category. Check Day by Day Subscription Details (Live Status)

Category	Subscription (times)	Shares Offered	Shares bid for
QIB	116.73	25,44,643	29,55,57,042
NII	64.95	19,08,482	12,75,40,116
    bNII (bids above ₹10L)	71.59	12,72,322	9,37,27,524
    sNII (bids below ₹10L)	51.65	6,36,161	3,38,12,592
Retail	17.15	44,53,125	7,85,72,439
Total	55.26	89,06,250	50,16,69,597
Total Application : 23,92,538

Innova Captab IPO Prospectus
  ›  Innova Captab IPO DRHP
  ›  Innova Captab IPO RHP
  ›  Anchor Investors in Innova Captab IPO
  ›  Innova Captab IPO Final Prospectus
Innova Captab IPO Listing Details
Listing Date	December 29, 2023
BSE Script Code	544067
NSE Symbol	INNOVACAP
ISIN	INE0DUT01020
Final Issue Price	₹448 per share
BSE Listing Group	B (Rolling)
Pre-Open Session - NSEPre-Open Session - BSE

Listing Day Trading Information
Price Details	NSE SME	NSE SME
Final Issue Price	₹448.00	₹448.00
Open	₹456.10	₹452.10
Low	₹452.00	₹452.10
High	₹547.30	₹542.50
Last Trade	₹545.15	₹541.40
